AU2002230164A1 - Crystal of pyrimidine nucleoside derivative - Google Patents

Crystal of pyrimidine nucleoside derivative

Info

Publication number: AU2002230164A1
Authority: AU; Australia
Prior art keywords: crystal; pyrimidine nucleoside; nucleoside derivative; derivative; pyrimidine
Prior art date: 2001-02-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002230164A

Other versions

AU2002230164B2 (en

Inventor

Susumu Harashima

Eiji Numagami

Keiichi Ohtsuka

Takashi Takita

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sankyo Co Ltd

Original Assignee

Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-09

Filing date

2002-02-06

Publication date

2003-02-20

2002-02-06 Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd

2002-02-06 Priority claimed from PCT/JP2002/000986 external-priority patent/WO2002064609A1/en

2003-02-20 Publication of AU2002230164A1 publication Critical patent/AU2002230164A1/en

2005-04-07 Application granted granted Critical

2005-04-07 Publication of AU2002230164B2 publication Critical patent/AU2002230164B2/en

2022-02-06 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Links

UAGYHIZGHDGMCY-FNCVBFRFSA-N (2R,3S,4R,5R)-2-(hydroxymethyl)-5-pyrimidin-1-ium-1-yloxolane-3,4-diol Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1[N+]1=CC=CN=C1 UAGYHIZGHDGMCY-FNCVBFRFSA-N 0.000 title 1

AU2002230164A 2001-02-09 2002-02-06 Crystal of pyrimidine nucleoside derivative Expired AU2002230164B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001033128		2001-02-09
JP2001-33128		2001-02-09
PCT/JP2002/000986 WO2002064609A1 (en)	2001-02-09	2002-02-06	Crystal of pyrimidine nucleoside derivative

Publications (2)

Publication Number	Publication Date
AU2002230164A1 true AU2002230164A1 (en)	2003-02-20
AU2002230164B2 AU2002230164B2 (en)	2005-04-07

Family

ID=18896929

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002230164A Expired AU2002230164B2 (en)	2001-02-09	2002-02-06	Crystal of pyrimidine nucleoside derivative

Country Status (21)

Country	Link
EP (1)	EP1364959B1 (en)
JP (2)	JP3748536B2 (en)
KR (1)	KR100679904B1 (en)
CN (1)	CN100408591C (en)
AT (1)	ATE361929T1 (en)
AU (1)	AU2002230164B2 (en)
BR (2)	BR0207102A (en)
CA (1)	CA2437994C (en)
CY (1)	CY1106685T1 (en)
CZ (1)	CZ303241B6 (en)
DE (1)	DE60220024T2 (en)
DK (1)	DK1364959T3 (en)
ES (1)	ES2286237T3 (en)
HU (1)	HU229294B1 (en)
IL (2)	IL157216A0 (en)
MX (1)	MXPA03007123A (en)
NZ (1)	NZ527393A (en)
PT (1)	PT1364959E (en)
RU (1)	RU2256666C2 (en)
WO (1)	WO2002064609A1 (en)
ZA (1)	ZA200306121B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2079291B1 (en)	1999-09-02	2013-06-19	Ibiden Co., Ltd.	Printed circuit board and method of manufacturing printed circuit board
GB0526419D0 (en) *	2005-12-23	2006-02-08	Cyclacel Ltd	Formulation
GB0625283D0 (en)	2006-12-19	2007-01-24	Cyclacel Ltd	Combination
JP5066737B2 (en) *	2007-04-06	2012-11-07	大鵬薬品工業株式会社	Antitumor agent for continuous intravenous administration containing cytidine derivative
US8124593B2 (en)	2007-11-05	2012-02-28	Cyclacel Limited	Methods of treatment using sapacitabine
GB0808357D0 (en)	2008-05-08	2008-06-18	Cyclacel Ltd	Process
US8530445B2 (en)	2008-06-09	2013-09-10	Cyclacel Limited	Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine
HUE046177T2 (en)	2011-04-14	2020-02-28	Cyclacel Ltd	Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia
CN108658873B (en) *	2012-03-15	2021-09-14	西建卡尔有限责任公司	Solid forms of an epidermal growth factor receptor kinase inhibitor
US10189872B2 (en) *	2015-03-09	2019-01-29	W. R. Grace & Co.-Conn	Crystalline form of nicotinamide riboside
EP3727400A4 (en)	2017-12-22	2021-10-20	Elysium Health, Inc.	Crystalline forms of nicotinamide riboside chloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2079413C (en) *	1991-09-30	2003-09-09	Masakatsu Kaneko	Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use

2002
- 2002-02-04 JP JP2002026232A patent/JP3748536B2/en not_active Expired - Lifetime
- 2002-02-06 AT AT02711347T patent/ATE361929T1/en active
- 2002-02-06 DK DK02711347T patent/DK1364959T3/en active
- 2002-02-06 DE DE60220024T patent/DE60220024T2/en not_active Expired - Lifetime
- 2002-02-06 BR BR0207102-9A patent/BR0207102A/en not_active Application Discontinuation
- 2002-02-06 HU HU0303159A patent/HU229294B1/en unknown
- 2002-02-06 CN CNB028079337A patent/CN100408591C/en not_active Expired - Lifetime
- 2002-02-06 ES ES02711347T patent/ES2286237T3/en not_active Expired - Lifetime
- 2002-02-06 WO PCT/JP2002/000986 patent/WO2002064609A1/en active IP Right Grant
- 2002-02-06 IL IL15721602A patent/IL157216A0/en active IP Right Grant
- 2002-02-06 RU RU2003124648/04A patent/RU2256666C2/en active
- 2002-02-06 CA CA2437994A patent/CA2437994C/en not_active Expired - Lifetime
- 2002-02-06 AU AU2002230164A patent/AU2002230164B2/en not_active Expired
- 2002-02-06 BR BRPI0207102A patent/BRPI0207102A8/en unknown
- 2002-02-06 PT PT02711347T patent/PT1364959E/en unknown
- 2002-02-06 CZ CZ20032111A patent/CZ303241B6/en not_active IP Right Cessation
- 2002-02-06 KR KR1020037010308A patent/KR100679904B1/en active IP Right Grant
- 2002-02-06 NZ NZ527393A patent/NZ527393A/en not_active IP Right Cessation
- 2002-02-06 MX MXPA03007123A patent/MXPA03007123A/en active IP Right Grant
- 2002-02-06 EP EP02711347A patent/EP1364959B1/en not_active Expired - Lifetime
2003
- 2003-08-04 IL IL157216A patent/IL157216A/en unknown
- 2003-08-07 ZA ZA2003/06121A patent/ZA200306121B/en unknown
2005
- 2005-08-09 JP JP2005230800A patent/JP4356998B2/en not_active Expired - Lifetime
2007
- 2007-07-02 CY CY20071100860T patent/CY1106685T1/en unknown

Similar Documents

Publication	Publication Date	Title
AU2002363005A1 (en)	2003-05-06	Derivatives of uk-2a
EP1436290B8 (en)	2013-12-04	Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor
AU2003242252A1 (en)	2003-12-22	Bicyclic pyrimidine derivatives
AU2002258400A1 (en)	2002-08-28	Methods of using pyrimidine-based antiviral agents
AU2003209077A1 (en)	2003-09-02	Pyrimidine compounds
AU2003281477A1 (en)	2004-02-09	4-amino-substituted pyrimidine derivatives
AU2003239644A1 (en)	2004-01-19	Crystallization of sugars
AU2002339185A1 (en)	2003-06-10	Pyridine and pyrimidine derivatives
AU2002330453A1 (en)	2003-06-05	Crystals of hydroxynorephedrine derivative
AU2002362806A1 (en)	2003-07-03	Pyrimidine derivatives
AU2002230164A1 (en)	2003-02-20	Crystal of pyrimidine nucleoside derivative
HUP0303159A3 (en)	2007-06-28	Crystal of pyrimidine nucleoside derivative
AU2003208467A1 (en)	2003-09-22	Pyrimidine compounds
AU2003230844A1 (en)	2003-10-27	Crystals and structures of pak4kd kinase pak4kd
AUPS143402A0 (en)	2002-05-09	Anomeric derivatives of monosaccharides
AU2003279690A1 (en)	2004-01-19	Synthesis of purine derivatives
GB0112802D0 (en)	2001-07-18	Pyrimidine derivatives
GB0112803D0 (en)	2001-07-18	Pyrimidine derivatives
AU2003231459A1 (en)	2003-11-10	Pyrimidine derivative
AU2003229459A1 (en)	2003-12-02	Methods of using thiazolidinedithione derivatives
AU2002368112A1 (en)	2004-02-16	Pyrimidine derivatives
AU2003285790A1 (en)	2004-07-14	Engaging structure of assistant glasses for glasses
AU2003253701A1 (en)	2004-01-06	11-c-substituted derivatives of clarithromycin
GB0119477D0 (en)	2001-10-03	Pyrimidine derivatives
AU2002311409A1 (en)	2002-12-09	Pyrimidine derivatives